Clinical trials sponsored by CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase breakdown

Conditions studied

Recruiting trials led by CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

• A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
  NCT07418736 · Phase: Phase 2 · Ages: 40 Years to 85 Years · Sex: All (male and female) · 1 location
• A Study of CM310 in Subjects With Moderate to Severe Asthma
  NCT05761028 · Phase: Phase 2, Phase 3 · Ages: 12 Years to 75 Years · Sex: All (male and female) · 1 location
• A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)
  NCT06505395 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast Cancer
  NCT06313086 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is CSPC ZhongQi Pharmaceutical Technology Co., Ltd. recruiting for?

CSPC ZhongQi Pharmaceutical Technology Co., Ltd. is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.